SHR5428
Product Specifications
Target
CDK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
SHR5428 is an orally active, selective, noncovalent inhibitor of CDK7, displaying potent enzymatic inhibition (IC50 = 2.3 nM) and effectively suppressing cellular activity in triple-negative breast cancer MDA-MB-468 cells (IC50 = 6.6 nM) [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2411605 3x 1.0 µg
TMPRSS13 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
040744-ML750 100 µL
RAB24 (S108) (Ras-related protein Rab-24, RAB24) (MaxLight 750) discontinued
Sign In for Pricing
View Details 